Focus Financial Network, Inc. Biogen Inc. Transaction History

Focus Financial Network, Inc.

$2.34 Trillion
Q2 2024

A detailed history of Focus Financial Network, Inc. transactions in Biogen Inc. stock. As of the latest transaction made, Focus Financial Network, Inc. holds 2,788 shares of BIIB stock, worth $511,068. This represents 0.03% of its overall portfolio holdings.

Number of Shares

2,788

Previous 2,788 -0.0%

Holding current value

$511,068

Previous $531 Million 19.85%

% of portfolio

0.03%

Previous 0.03%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	BUY	$212.02 - $267.71 $591,111 - $746,375	2,788 New	2,788 $531 Million
Q3 2023 Jul 22, 2024	SELL	$253.3 - $285.89 $3,799 - $4,288	-15 Reduced 0.53%	2,795 $718 Million
Q2 2023 Jul 22, 2024	SELL	$275.25 - $318.06 $187,170 - $216,280	-680 Reduced 19.48%	2,810 $800 Million
Q1 2023 Jul 22, 2024	BUY	$256.56 - $292.34 $180,105 - $205,222	702 Added 25.18%	3,490 $970 Million
Q4 2022 Jul 24, 2024	SELL	$252.44 - $306.72 $127,229 - $154,586	-504 Reduced 12.6%	3,496 $968 Million
Q3 2022 Jul 24, 2024	SELL	$194.69 - $268.46 $8,955 - $12,349	-46 Reduced 1.31%	3,465 $925 Million
Q2 2022 Jul 24, 2024	BUY	$187.54 - $223.02 $19,504 - $23,194	104 Added 3.05%	3,511 $716 Million
Q1 2022 Jul 24, 2024	BUY	$193.77 - $244.14 $494,501 - $623,045	2,552 Added 298.48%	3,407 $718 Million
Q4 2021 Jul 24, 2024	SELL	$223.92 - $287.77 $38,066 - $48,920	-170 Reduced 16.59%	855 $205 Million
Q3 2021 Jul 24, 2024	SELL	$282.99 - $369.05 $49,523 - $64,583	-175 Reduced 14.58%	1,025 $290 Million
Q2 2021 Jul 24, 2024	SELL	$259.0 - $414.71 $4,662 - $7,464	-18 Reduced 1.48%	1,200 $416 Million
Q1 2021 Jul 24, 2024	SELL	$242.95 - $284.63 $716,702 - $839,658	-2,950 Reduced 70.78%	1,218 $341 Million
Q4 2020 Jul 24, 2024	BUY	$236.26 - $355.63 $51,032 - $76,816	216 Added 5.47%	4,168 $1.02 Billion
Q3 2020 Jul 24, 2024	BUY	$264.77 - $305.71 $12,179 - $14,062	46 Added 1.18%	3,952 $1.12 Billion
Q2 2020 Jul 24, 2024	BUY	$258.66 - $342.55 $33,108 - $43,846	128 Added 3.39%	3,906 $1.05 Billion
Q1 2020 Jul 24, 2024	BUY	$268.85 - $341.04 $266,161 - $337,629	990 Added 35.51%	3,778 $1.2 Billion
Q4 2019 Jul 24, 2024	SELL	$220.06 - $304.07 $2,200 - $3,040	-10 Reduced 0.25%	4,000 $1.19 Billion
Q3 2019 Jul 24, 2024	SELL	$217.44 - $243.88 $40,443 - $45,361	-186 Reduced 4.43%	4,010 $934 Million
Q2 2019 Jul 24, 2024	BUY	$219.29 - $241.72 $3,947 - $4,350	18 Added 0.43%	4,196 $981 Million
Q1 2019 Jul 24, 2024	BUY	$216.71 - $338.96 $301,226 - $471,154	1,390 Added 49.86%	4,178 $988 Million

Others Institutions Holding BIIB

# of Institutions

1,048

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $26.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Focus Financial Network, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Focus Financial Network, Inc. with notifications on news.

Account

Focus Financial Network, Inc. Biogen Inc. Transaction History